EDITORIALS

When Will Melanoma Vaccines Be Proven Effective?

Jeffrey A. Sosman, Ashani T. Weeraratna, and Vernon K. Sondak

JCO Feb 1 2004: 387–389. First published on Dec 22 2003; 10.1200/JCO.2004.11.950. [Full Text] [PDF]

Use of Granulocyte Colony-Stimulating Factor Following Hematopoietic Cell Transplantation: Does Haste Make Waste?

Frederick R. Appelbaum

JCO Feb 1 2004: 390–391. First published on Dec 22 2003; 10.1200/JCO.2004.11.963. [Full Text] [PDF]

Do Estimates of Long-Term Survival Tell Us Whether Patients Diagnosed With Breast Cancer Before Age 50 Years Are Ever Cured?

Stephanie Green

JCO Feb 1 2004: 392–394. First published on Dec 22 2003; 10.1200/JCO.2004.11.972. [Full Text] [PDF]

The "Skinny" on Obesity and Prostate Cancer Prognosis

Alfred I. Neugut, Allen C. Chen, and Daniel P. Petrylak

JCO Feb 1 2004: 395–398. First published on Dec 22 2003; 10.1200/JCO.2004.11.973. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's Sarcoma

Susan E. Krown

JCO Feb 1 2004: 399–402. [Full Text] [PDF]

ORIGINAL REPORTS
Immunotherapy
	Immunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine
	David Berd, Takami Sato, Henry C. Maguire, Jr, John Kairys, and Michael J. Mastrangelo
	JCO Feb 1 2004: 403–415. First published on Dec 22 2003; 10.1200/JCO.2004.06.043. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Treatment With Granulocyte Colony-Stimulating Factor After Allogeneic Bone Marrow Transplantation for Acute Leukemia Increases the Risk of Graft-Versus-Host Disease and Death: A Study From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
	Olle Ringdén, Myriam Labopin, Norbert-Claude Gorin, Katarina Le Blanc, Vanderson Rocha, Eliane Gluckman, Jules Reiffers, William Arcese, Jaak M. Vossen, Jean-Pierre Jouet, Catherine Cordonnier, and Francesco Frassoni
	JCO Feb 1 2004: 416–423. First published on Dec 22 2003; 10.1200/JCO.2004.06.102. [Abstract] [Full Text] [PDF]
	Low-Dose Thalidomide Ameliorates Cytopenias and Splenomegaly in Myelofibrosis With Myeloid Metaplasia: A Phase II Trial
	Monia Marchetti, Giovanni Barosi, Francesca Balestri, Gianluca Viarengo, Sara Gentili, Sara Barulli, Jean-Loup Demory, Fiorella Ilariucci, Antonio Volpe, Dominique Bordessoule, Alberto Grossi, Marie Caroline Le Bousse-Kerdiles, Andrea Caenazzo, Alessandro Pecci, Antonietta Falcone, Giorgio Broccia, Cesarina Bendotti, Fredric Bauduer, Francesco Buccisano, and Brigitte Dupriez
	JCO Feb 1 2004: 424–431. [Abstract] [Full Text] [PDF]

Breast Cancer
	Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured?
	Hermann Brenner and Timo Hakulinen
	JCO Feb 1 2004: 432–438. First published on Dec 22 2003; 10.1200/JCO.2004.04.067. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy
	Christopher L. Amling, Robert H. Riffenburgh, Leon Sun, Judd W. Moul, Raymond S. Lance, Leo Kusuda, Wade J. Sexton, Douglas W. Soderdahl, Timothy F. Donahue, John P. Foley, Andrew K. Chung, and David G. McLeod
	JCO Feb 1 2004: 439–445. First published on Dec 22 2003; 10.1200/JCO.2004.03.132. [Abstract] [Full Text] [PDF]
	Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group
	Stephen J. Freedland, William J. Aronson, Christopher J. Kane, Joseph C. Presti, Jr, Christopher L. Amling, David Elashoff, and Martha K. Terris
	JCO Feb 1 2004: 446–453. First published on Dec 22 2003; 10.1200/JCO.2004.04.181. [Abstract] [Full Text] [PDF]
	Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma
	Robert J. Motzer, Jennifer Bacik, Lawrence H. Schwartz, Victor Reuter, Paul Russo, Stephanie Marion, and Madhu Mazumdar
	JCO Feb 1 2004: 454–463. [Abstract] [Full Text] [PDF]
	Relapse-Free and Overall Survival in Patients With Pathologic Stage II Nonseminomatous Germ Cell Cancer Treated With Etoposide and Cisplatin Adjuvant Chemotherapy
	G. Varuni Kondagunta, Joel Sheinfeld, Madhu Mazumdar, Tania V. Mariani, Dean Bajorin, Jennifer Bacik, George J. Bosl, and Robert J. Motzer
	JCO Feb 1 2004: 464–467. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms' Tumor Study Group
	Nita L. Seibel, Sierra Li, Norman E. Breslow, J. Bruce Beckwith, Daniel M. Green, Gerald M. Haase, Michael L. Ritchey, Patrick R.M. Thomas, Paul E. Grundy, Jerry Z. Finklestein, Tae Kim, Stephen J. Shochat, Panayotis P. Kelalis, and Giulio J. D'Angio
	JCO Feb 1 2004: 468–473. [Abstract] [Full Text] [PDF]

Molecular Oncology
	Combination of Cytology, Fluorescence In Situ Hybridization for Aneuploidy, and Reverse-Transcriptase Polymerase Chain Reaction for Human Mammaglobin/Mammaglobin B Expression Improves Diagnosis of Malignant Effusions
	Michael Fiegl, Margot Haun, Anita Massoner, Jens Krugmann, Elisabeth Müller-Holzner, Rene Hack, Wolfgang Hilbe, Christian Marth, Hans-Christoph Duba, Günther Gastl, and Kurt Grünewald
	JCO Feb 1 2004: 474–483. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized Trials
	JCO Feb 1 2004: 484–492. [Abstract] [Full Text] [PDF]
	Surveillance of Duodenal Adenomas in Familial Adenomatous Polyposis Reveals High Cumulative Risk of Advanced Disease
	Jean-Christophe Saurin, Christelle Gutknecht, Bertrand Napoleon, Annick Chavaillon, René Ecochard, Jean-Yves Scoazec, Thierry Ponchon, and Jean-Alain Chayvialle
	JCO Feb 1 2004: 493–498. [Abstract] [Full Text] [PDF]

Radiation Oncology
	Urinary VEGF and MMP Levels As Predictive Markers of 1-Year Progression-Free Survival in Cancer Patients Treated With Radiation Therapy: A Longitudinal Study of Protein Kinetics Throughout Tumor Progression and Therapy
	Linda W. Chan, Marsha A. Moses, Elizabeth Goley, Mary Sproull, Thierry Muanza, C. Norman Coleman, William D. Figg, Paul S. Albert, Cynthia Ménard, and Kevin Camphausen
	JCO Feb 1 2004: 499–506. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Effect of a Cognitive Behavioral Intervention on Reducing Symptom Severity During Chemotherapy
	Charles Given, Barbara Given, Mohammad Rahbar, Sangchoon Jeon, Ruth McCorkle, Bernadine Cimprich, Andrzej Galecki, Sharon Kozachik, Albert Brady, Mary Jo Fisher-Malloy, Kathy Courtney, and Elizabeth Bowie
	JCO Feb 1 2004: 507–516. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Antioxidants and Cancer Therapy: A Systematic Review
	Elena J. Ladas, Judith S. Jacobson, Deborah D. Kennedy, Katherine Teel, Aaron Fleischauer, and Kara M. Kelly
	JCO Feb 1 2004: 517–528. [Abstract] [Full Text] [PDF]
	Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Systematic Review and Meta-Analysis
	Sanjay Popat, Athena Matakidou, and Richard S. Houlston
	JCO Feb 1 2004: 529–536. [Abstract] [Full Text] [PDF]

SPECIAL ARTICLE
	Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group
	Howard I. Scher, Mario Eisenberger, Anthony V. D'Amico, Susan Halabi, Eric J. Small, Michael Morris, Michael W. Kattan, Mack Roach, Philip Kantoff, Kenneth J. Pienta, Michael A. Carducci, David Agus, Susan F. Slovin, Glenn Heller, William Kevin Kelly, Paul H. Lange, Daniel Petrylak, William Berg, Celestra Higano, George Wilding, Judd W. Moul, Alan N. Partin, Christopher Logothetis, and Howard R. Soule
	JCO Feb 1 2004: 537–556. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Lymphoma Manifestations: CASE 1. Natural Killer Cell Leukemia With Dermal Erythema and Vascular Epidermal Growth Factor Production

Robin B. Gear, Sue Heffelfinger, and Herbert C. Flessa

JCO Feb 1 2004: 557–558. [Full Text] [PDF]

Unusual Lymphoma Manifestations: CASE 2. Myocardial Lymphoma Presenting As Atrial Flutter

Michael A. Thompson, Amy Harker-Murray, Adam J. Locketz, and Panithaya Chareonthaitawee

JCO Feb 1 2004: 558–560. [Full Text] [PDF]

Unusual Lymphoma Manifestations: CASE 3. CD8+ T-Cell Prolymphocytic Leukemia

Hikaru Nakajima, Masayuki Oki, and Kiyoshi Ando

JCO Feb 1 2004: 560–562. [Full Text] [PDF]

ART OF ONCOLOGY

The Day One Talk

Jennifer W. Mack and Holcombe E. Grier

JCO Feb 1 2004: 563–566. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Anaphylactoid Reactions to Isosulfan Blue Dye During Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis

Chandrajit P. Raut, M. Denise Daley, Kelly K. Hunt, Jeri Akins, Merrick I. Ross, S. Eva Singletary, Gailen D. Marshall, Jr, Funda Meric-Bernstam, Gildy Babiera, Barry W. Feig, Frederick C. Ames, and Henry M. Kuerer

JCO Feb 1 2004: 567–568. [Full Text] [PDF]

HER2/neu Expression and Hormonal Therapy in Early Breast Cancer: Can Muddy Waters Become Clear?

Gianluigi Ferretti, Serena Di Cosimo, Diana Giannarelli, Paolo Carlini, Paola Papaldo, Andrea Alimonti, Alessandra Fabi, Mario Mandalà, Michele Milella, Enzo Maria Ruggeri, and Francesco Cognetti

JCO Feb 1 2004: 568–569. [Full Text] [PDF]

Acute Lymphoblastic Leukemia- Relapse Study of the Berlin-Frankfurt-Münster Group (ALL-REZ BFM) Experience: Early Treatment Intensity Makes the Difference

Ralf Herold, Arend von Stackelberg, Reinhard Hartmann, Bernhard Eisenreich, and Günter Henze

JCO Feb 1 2004: 569–570. [Full Text] [PDF]

In Reply:

Charles A. Schiffer

JCO Feb 1 2004: 570–571. [Full Text] [PDF]

Physician-Patient Communication in Phase I Cancer Trials

Ruprecht Nitschke

JCO Feb 1 2004: 571–572. [Full Text] [PDF]

In Reply:

Neal J. Meropol, Liana D. Castel, Kevin A. Schulman, and Kevin P. Weinfurt

JCO Feb 1 2004: 572–573. [Full Text] [PDF]

Is Lanreotide and/or Interferon Alfa an Adequate Therapy for Neuroendocrine Tumors?

Verena Völter and Christian Peschel

JCO Feb 1 2004: 573. [Full Text] [PDF]

Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors

Nicola Fazio and Kjell Oberg

JCO Feb 1 2004: 573-a–574. [Full Text] [PDF]

In Reply:

S. Faiss, U.-F. Pape, and B. Wiedenmann

JCO Feb 1 2004: 574–575. [Full Text] [PDF]

Errata

ERRATUM

JCO Feb 1 2004: 576. [Full Text] [PDF]

ERRATUM

JCO Feb 1 2004: 576-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.